These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25232128)

  • 21. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer.
    Al Shemaili J; Mensah-Brown E; Parekh K; Thomas SA; Attoub S; Hellman B; Nyberg F; Adem A; Collin P; Adrian TE
    Eur J Cancer; 2014 May; 50(7):1391-8. PubMed ID: 24462376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model.
    Capistrano I R; Vangestel C; Vanpachtenbeke H; Fransen E; Staelens S; Apers S; Pieters L
    Phytomedicine; 2016 Nov; 23(12):1434-1440. PubMed ID: 27765363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.
    Chen J; Wu SY; Ou-Yang ZG; Zhen YS
    Acta Pharmacol Sin; 2008 May; 29(5):614-9. PubMed ID: 18430374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer.
    Ono H; Basson MD; Ito H
    Oncotarget; 2016 Aug; 7(32):51301-51310. PubMed ID: 27322077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase.
    Kuroda H; Tachikawa M; Uchida Y; Inoue K; Ohtsuka H; Ohtsuki S; Unno M; Terasaki T
    Eur J Pharm Sci; 2017 May; 103():116-121. PubMed ID: 28215943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
    Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
    Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y; Liu H; Xue R; Tang W; Zhang S
    Dig Dis Sci; 2018 Dec; 63(12):3367-3375. PubMed ID: 30155839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
    Bianco C; Giovannetti E; Ciardiello F; Mey V; Nannizzi S; Tortora G; Troiani T; Pasqualetti F; Eckhardt G; de Liguoro M; Ricciardi S; Del Tacca M; Raben D; Cionini L; Danesi R
    Clin Cancer Res; 2006 Dec; 12(23):7099-107. PubMed ID: 17145834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
    Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
    PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
    Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG
    Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways.
    Wang F; Tian X; Zhang Z; Ma Y; Xie X; Liang J; Yang C; Yang Y
    Int J Cancer; 2018 May; 142(9):1938-1951. PubMed ID: 29238973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer.
    Awasthi N; Zhang C; Ruan W; Schwarz MA; Schwarz RE
    Mol Cancer Ther; 2012 Dec; 11(12):2644-53. PubMed ID: 23047891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells.
    Huang XY; Wang HC; Yuan Z; Li A; He ML; Ai KX; Zheng Q; Qin HL
    Acta Pharmacol Sin; 2010 Jun; 31(6):741-5. PubMed ID: 20523344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.
    Kimura K; Sawada T; Komatsu M; Inoue M; Muguruma K; Nishihara T; Yamashita Y; Yamada N; Ohira M; Hirakawa K
    Clin Cancer Res; 2006 Aug; 12(16):4925-32. PubMed ID: 16914581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer.
    Lee SH; Ryu JK; Lee KY; Woo SM; Park JK; Yoo JW; Kim YT; Yoon YB
    Cancer Lett; 2008 Jan; 259(1):39-49. PubMed ID: 17967505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.